Biomedical Engineering Reference
In-Depth Information
[184] Hauser RG, Cannom D, Hayes DL, Parsonnet V, Hayes J, Ratliff N 3rd, Tyers GF, Ep‐
stein AE, Vlay SC, Furman S, Gross J. Long-term structural failure of coaxial polyur‐
ethane implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol.
2002;25(6):879-882.
[185] Stokes KB, Church T. Ten-year experience with implanted polyurethane lead insula‐
tion. Pacing Clin Electrophysiol. 1986;;9(6 Pt 2):1160-1165.
[186] Santerre JP, Woodhouse K, Laroche G, Labow RS. Understanding the biodegradation
of polyurethanes: From classical implants to tissue engineering materials. Biomateri‐
als 2005;26(35):7457-7470.
[187] Wang Y. Patent: Implantable Medical Devices Fabricated From Polyurethanes With
Grafted Radiopaque Groups. IPC8 Class: AA61F282FI, USPC Class: 623 134, Class
name: Prosthesis (i.e., artificial body members), parts thereof, or aids and accessories
therefor arterial prosthesis (i.e., blood vessel) having marker (e.g., color, radiopaque,
etc.), Publication date: 2009-10-15, Patent application number: 20090259297
[188] Stachelek SJ, Alferiev I, Connolly JM, Sacks M, Hebbel RP, Bianco R, Levy RJ. Choles‐
terol-modified polyurethane valve cusps demonstrate blood outgrowth endothelial
cell adhesion post-seeding
in vitro
and
in vivo
. Ann Thorac Surg. 2006 Jan;81(1):47-55.
[189] Ghanbari H, Viatge H, Kidane AG, Burriesci G, Tavakoli M, Seifalian AM. Polymeri‐
ca heart valves: new materials, emerging hopes. Trends in Biotechnology 2009;27(6):
359-367.
[190] Gwendolyn M.R. Wetzels, Leo H. Koole. Photoimmobilisation of poly(N-vinylpyrro‐
lidinone) as a means to improve haemocompatibility of polyurethane biomaterials.
Biomaterials 1999;20(20):1879}-1887.
[191] Staniszewska-Kuś J, Paluch D, Krzemień-Dabrowska A, Zywicka B, Solski L.Tissue
reaction to implanted polyurethane designed for parts of the artificial heart. Polym
Med. 1995;25(3-4):3-18.
[192] Stachelek SJ, Alferiev I, Choi H, Chan CW, Zubiate B, Sacks M, Composto R, Chen I-
W, Levy R. Prevention of oxidative degradation of polyurethane by covalent attach‐
ment of di-tert-butylphenol residues. J Biomed Mater Res A. 2006;78(4):653-661).
[193] Stachelek SJ, Alferiev I, Connolly JM, Sacks M, Hebbel RP, Bianco R, Levy RJ. Choles‐
terol-modified polyurethane valve cusps demonstrate blood outgrowth endothelial
cell adhesion post-seeding in vitro and
in vivo
Ann Thorac Surg. 2006 Jan; 81(1):47-55.
[194] Alferiev I, Stachelek SJ, Lu ZB, Fu AL, Tiffany L. Sellaro TL, Jeanne M. Connolly JM,
Richard W. Bianco RW, Michael S. Sacks MS, Robert J. Levy RJ. Prevention of polyur‐
ethane valve cusp calcification with covalently attached bisphosphonate diethylami‐
no moieties. J Biomed Mater Res A. 2003; 66(2):385-395.
[195] Chris Smith. Implantable PU developer wins heart valve patent. Time:2009-08-03.
Search WWH ::
Custom Search